Drug Discovery
- All
- Analytical Services
- Bioanalytical Services
- Bioassay Development
- Biologics, Proteins, Vaccines
- Biosimilars
- Chemistry
- Clinical Trials
- Drug Delivery
- Drug Development
- Drug Discovery
- Formulation Development
- Information Technology
- Laboratory Testing
- Methods Development
- Microbiology
- Preclinical Outsourcing
- R&D
- Toxicology
-
Drug Development | Drug Discovery | R&D
R&D Outsourcing Trends
Highly specialized drug products and capacity needs drive increased reliance on contract service providers.Kristin Brooks, Managing Editor, Contract Pharma 10.14.20
-
Bio News | Bioanalytical Services | Bioassay Development | Breaking News | Collaborations & Alliances | Drug Discovery | Industry News
Axxam and Fujifilm Cellular Dynamics Enter Alliance
Partner to deliver integrated hiPSC drug discovery solutions.Contract Pharma Staff 10.08.20
-
Breaking News | cGMP Manufacture | Clinical Trials | Drug Development | Drug Discovery | Industry News
BioDuro, Sundia Partner as New CRDMO
Advent International investment creates services company with over 2,000 employees and 10 facilities in China and U.S.Contract Pharma Staff 09.25.20
-
Breaking News | Drug Discovery | Industry News | Information Technology
Sartorius Joins DFKI to Support AI for Advanced Medicines
Conducting research on deep learning algorithms for modeling of biological systems and for optimization of biopharmaceutical production processes.Contract Pharma Staff 09.25.20
-
Breaking News | Drug Discovery | Industry News
Sygnature Discovery Acquires XenoGesis
Expands its DMPK capabilities and expertise.Contract Pharma Staff 09.24.20
-
Breaking News | Drug Development | Drug Discovery | Industry News
Scenic Biotech, Genentech Enter Genetic Modifier Alliance
Strategic collaboration will leverage Scenic Biotech’s disease modifying Cell-Seq platform in deal that could exceed $375M.Contract Pharma Staff 09.21.20
-
Bioassay Development | Drug Development | Drug Discovery
Technology Selection for Bioavailability Enhancement
Selection of the proper technology can make the difference between development success or failure. Learn more in this whitepaper from Lonza Pharma & Biotech.
-
Breaking News | Collaborations & Alliances | Drug Discovery | Industry News
Evotec and Bioaster Partner
Will put forward new research for infectious diseases.Contract Pharma Staff 09.14.20
-
Breaking News | Drug Development | Drug Discovery | Industry News
Grifols to Acquire Alkahest for $146M
Enhances discovery research and development to identify therapies for age-related diseases.Contract Pharma Staff 09.09.20
-
Breaking News | Drug Development | Drug Discovery
Gilead Sciences Signs Agreement with Jounce Therapeutics
Licenses Jounce’s JTX-1811, a monoclonal antibody targeting tumor-infiltrating T regulatory cells.Contract Pharma Staff 09.02.20
-
Breaking News | CRO News | Drug Discovery | Facilities | Industry News
Eurofins Expands Chemistry Capacity
Its new 63,000 square foot facility in Spain is nearing completion.Contract Pharma Staff 08.24.20
-
Bio News | Breaking News | Collaborations & Alliances | Drug Development | Drug Discovery | Industry News
Evotec and Novo Nordisk Form Strategic Alliance
Collaborate to develop novel therapies for kidney diseases.Contract Pharma Staff 08.18.20
-
Breaking News | Collaborations & Alliances | Drug Development | Drug Discovery
GEMoaB, Intellia Enter Cellular Immunotherapy Research Pact
Will combine GEMoaB's RevCAR technology platform with Intellia's genome editing technologies to discover and develop allogeneic cellular immunotherapies.Contract Pharma Staff 07.20.20
-
Breaking News | Collaborations & Alliances | Drug Development | Drug Discovery | Industry News
Merck Inks $425M Oncology Deal with Foghorn Therapeutics
To discover and develop novel oncology therapeutics against transcription factor target.Contract Pharma Staff 07.08.20
-
Breaking News | Collaborations & Alliances | Drug Development | Drug Discovery
BioInvent, Pfizer Extend Immunotherapy Research Term
Allows the companies to further identify and characterize new targets and antibodies leveraging BioInvent's F.I.R.S.T drug discovery platform.Contract Pharma Staff 07.01.20
-
Biologics, Proteins, Vaccines | Drug Discovery
Cell Therapy for Solid Tumors
Is base editing the solution for solid tumor-based cell therapy?Online Exclusives Jonathan Frampton, Corporate Development Partner, Horizon Discovery 06.26.20
-
Breaking News | Drug Discovery | Industry News | Preclinical Outsourcing
Evotec, Samsara BioCapital, and KCK Launch Autobahn Labs
A novel early stage drug discovery incubator.Contract Pharma Staff 06.24.20
-
Analytical Services | Biologics, Proteins, Vaccines | Drug Development | Drug Discovery | Laboratory Testing
A Shifting Drug Development Landscape Amid COVID-19 Crisis
Responding to demand for challenging assays and custom solutions required for complex molecules, biologics, vaccines and other innovative therapies.Online Exclusives Kristin Brooks, Contract Pharma 06.22.20
-
Bioanalytical Services | Drug Discovery | Industry News
Lonza, Sanquin Reagents Enter Strategic Pact
Expands Lonza’s portfolio of endotoxin testing products and enables drug developers and QC labs to leverage sustainable MAT method.Contract Pharma Staff 05.28.20
-
Breaking News | Collaborations & Alliances | Drug Discovery | Industry News
Oncodesign and HitGen Enter Strategic Partnership
Aim to expand Integrated Drug Discovery Services.Contract Pharma Staff 05.27.20
